Stock Update (NASDAQ:REGN): Biotechnology Stocks under Review — Alnylam Pharma, Puma Biotechnology, Regeneron Pharma, and Spectrum Pharma

[Accesswire] – NEW YORK, NY / ACCESSWIRE / February 22, 2016 / Park Lane Advisor has initiated coverage on the following equities: Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Puma Biotechnology Inc. (NYSE: PBYI), Regeneron … Read more on this. Regeneron Pharmaceuticals, Inc. (REGN) , valued at $42.15B, started trading this morning at $399.05. Today, shares have traded between $397.11 and $405.62 per share with a trailing 52-week range being $350.26 to $605.93. REGN shares are currently priced at 33.33x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s -1.62x earnings multiple. According to a consensus of 16 analysts, the earnings estimate of $2.65 per share would be $0.23 worse than the year-ago quarter and a $0.90 sequential decrease. Investors should also note that the full-year EPS estimate of $11.62 is a $0.45 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $1.18 Billion. If realized, that would be a 35.69% increase over the year-ago quarter. Recently, Chardan Capital Markets upgraded REGN from Sell to Neutral (Feb 16, 2016). Previously, Canaccord Genuity downgraded REGN from Buy to Hold. The average price target for REGN shares is $522.10, which is 30.84% above where the stock opened this morning. See more in (NASDAQ:REGN) Similar Articles: Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron and Sanofi Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015